Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02082717 · ClinicalTrials.gov registry record · Phase 4
The Impact of Neut During Potassium Chloride Replacement on Pain and Incidence of Phlebitis
A Phase 4 study, sponsored by Baptist Health South Florida.
- Terminated
- Registry status
- Phase 4
- Development phase
- 17
- Enrollment target
NCT02082717 is a Phase 4 study that was terminated before completion, run by Baptist Health South Florida. The registered enrollment target is 17 participants.
The verdict
NCT02082717, a Phase 4 study, was terminated before completion, sponsored by Baptist Health South Florida.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 17 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the impact of 4% sodium bicarbonate additive during peripheral intravenous potassium chloride replacement therapy for adult patients in a Medical/Surgical unit. Using a randomized controlled double blinded experimental study design, patients who are 21 years or older are alert, awake, and oriented at the time of enrollment and have been ordered peripheral intravenous potassium chloride replacement will be recruited from one Medical/Surgical during the first 24-48 hours of their admission.
Interventions
- DRUG potassium chloride replacement
- DRUG Experimental - 4% Sodium Bicarbonate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2014-02-25 |
| Est. Completion | 2018-08-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02082717
The ClinicalTrials.gov registry entry for NCT02082717 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baptist Health South Florida, which has 40 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which potassium chloride replacement is the first listed.
NCT02082717 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02082717 about?
NCT02082717 is a clinical study titled "The Impact of Neut During Potassium Chloride Replacement on Pain and Incidence of Phlebitis". The purpose of this study is to examine the impact of 4% sodium bicarbonate additive during peripheral intravenous potassium chloride replacement therapy for adult patients in a Medical/Surgical unit. Using a randomized controlled double blinded experimental study design, patients who are 21 years o...
What is the current status of trial NCT02082717?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 17 participants. The study started on 2014-02-25. Estimated completion is 2018-08-03.
What interventions are being tested in trial NCT02082717?
The interventions under investigation include: potassium chloride replacement (DRUG), Experimental - 4% Sodium Bicarbonate (DRUG).
Who is sponsoring clinical trial NCT02082717?
This trial is sponsored by Baptist Health South Florida, which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.